ANR logo

Anatara Lifesciences Ltd Stock Price

ASX:ANR Community·AU$2.8m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

ANR Share Price Performance

AU$0.009
0.00 (0.00%)
AU$0.009
0.00 (0.00%)
Price AU$0.009

ANR Community Narratives

There are no narratives available yet.

Trending Discussion

No trending discussion available.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with slight risk.

4 Risks
1 Reward

Anatara Lifesciences Ltd Key Details

AU$318.4k

Revenue

AU$0

Cost of Revenue

AU$318.4k

Gross Profit

AU$1.3m

Other Expenses

-AU$933.2k

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
-0.003
100.00%
-293.10%
0%
View Full Analysis

About ANR

Founded
2010
Employees
n/a
CEO
David Brookes
WebsiteView website
anataralifesciences.com

Anatara Lifesciences Ltd engages in the research, development, and commercialization of evidence-based solutions for gastrointestinal diseases in Australia. The company’s products include irritable bowel syndrome; and Detach for the treatment of diarrhea in piglets. It also develops anti-obesity project, an oral complementary medication to assist weight reduction and control. Anatara Lifesciences Ltd was incorporated in 2010 and is based in Adelaide, Australia.

Recent ANR News & Updates

Recent updates

No updates